LGBT Cancer Project

Therapeutic Areas: Oncology | Family Medicine

Lymphocytic Leukemia, Chronic Clinical Trials

A listing of Lymphocytic Leukemia, Chronic medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Mayo Clinic
Phoenix Arizona

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Arkansas

Genesis Cancer Center
Hot Springs Arkansas

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

California

Pacific Cancer Medical Center Inc
Anaheim California

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Alta Bates Summit Medical Center
Berkeley California

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

City of Hope National Medical Center
Duarte California

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

University of California Irvine
Irvine California

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

UC San Diego Moores Cancer Center
La Jolla California

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

UCLA Hematology/Oncology
Los Angeles California

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Southern California Oncology Research Alliance
Los Angeles California

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

St Joseph Heritage Healthcare
Santa Rosa California

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Stanford Cancer Center
Stanford California

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

UPDATED

Duarte California 91010

Patients are needed to participate in a clinical research study evaluating BTCT4465A and Obinutuzumab for the treatment of Lymphocytic Leukemia, Chronic or Lymphoma, Non Hodgkin

La Jolla California 92093

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Colorado

Denver Colorado 80218

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Connecticut

UPDATED

New Haven Connecticut 06510

Patients are needed to participate in a clinical research study evaluating BTCT4465A and Obinutuzumab for the treatment of Lymphocytic Leukemia, Chronic or Lymphoma, Non Hodgkin

District of Columbia

Georgetown University Medical Center
Washington District of Columbia

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Florida

Mayo Clinic Jacksonville
Jacksonville Florida

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

H Lee Moffitt Cancer Center and Research Institute
Tampa Florida

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Georgia

University Cancer and Blood Center, LLC
Athens Georgia

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Illinois

Ingalls Memorial Hospital
Harvey Illinois

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Illinois Cancer Care
Peoria Illinois

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Indiana

Indiana University Health Arnett Inc
Lafayette Indiana

ACE-CL-007: Study of Obinutuzumab + Chlorambucil, ACP-196 + Obinutuzumab, and ACP-196 Monotherapy in Subjects With Previously Untreated CLL

Iowa

Physicians' Clinic of Iowa PC
Cedar Rapids Iowa

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Kansas

Cancer Center of Kansas
Wichita Kansas

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Kentucky

Montgomery Cancer Center
Mount Sterling Kentucky

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Minnesota

Mayo Clinic
Rochester Minnesota

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

CentraCare Health
St. Cloud Minnesota

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Park Nicollet Institute
St. Louis Park Minnesota

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Missouri

UPDATED

St. Louis Missouri 63110

Patients are needed to participate in a clinical research study evaluating BTCT4465A and Obinutuzumab for the treatment of Lymphocytic Leukemia, Chronic or Lymphoma, Non Hodgkin

Montana

Frontier Cancer Center and Blood Institute
Billings Montana

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Nevada

Southern Nevada Cancer Research Foundation
Las Vegas Nevada

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

New Jersey

Hunterdon Regional Cancer Center
Flemington New Jersey

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Hackensack University Medical Center
Hackensack New Jersey

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

New York

Clinical Research Alliance Inc
Lake Success New York

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Long Island Jewish Medical Center
New Hyde Park New York

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Columbia University Medical Center
New York New York

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Weill Cornell Medical College
New York New York

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Icahn School of Medicine at Mount Sinai
New York New York

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Buffalo New York 14263

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Commack New York 11725

Patients are needed to participate in a clinical research study evaluating BTCT4465A and Obinutuzumab for the treatment of Lymphocytic Leukemia, Chronic or Lymphoma, Non Hodgkin

New York New York 10065

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

North Carolina

Duke University Medical Center
Durham North Carolina

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Ohio

Gabrail Cancer Center
Canton Ohio

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Ohio State University Comprehensive Cancer Center
Columbus Ohio

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Columbus Ohio 43210

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Pennsylvania

Maryland Oncology Hematology PA
Gettysburg Pennsylvania

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Penn State Milton S Hershey Medical Center
Hershey Pennsylvania

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Abramson Cancer Center of The University of Pennsylvania
Philadelphia Pennsylvania

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Tennessee

Nashville Tennessee 37203

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia